Aim: To investigate the protective effects of prostaglandin E 1 (PGE 1 ) against H 2 O 2 -induced oxidative damage on human umbilical vein endothelial cells (HUVECs). Methods: HUVECs were pretreated with PGE 1 (0.25, 0.50, and 1.00 µmol/L) for 24 h and exposed to H 2 O 2 (200 µmol/L) for 12 h, and cell viability was measured by the MTT assay. LDH, NO, SOD, GSH-Px, MDA, ROS, and apoptotic percentage were determined. eNOS expression was measured by Western blotting and real-time PCR. Results: PGE 1 (0.25−1.00 µmol/L) was able to markedly restore the viability of HUVECs under oxidative stress, and scavenged intracellular reactive oxygen species induced by H 2 O 2 . PGE 1 also suppressed the production of lipid peroxides, such as MDA, restored the activities of endogenous antioxidants including SOD and GSH-Px, and inhibited cell apoptosis. In addition, PGE 1 significantly increased NO content, eNOS protein, and mRNA expression. Conclusion: PGE 1 effectively protected endothelial cells against oxidative stress induced by H 2 O 2 , an activity that might depend on the up-regulation of NO expression.
Introduction
The endothelium is located in a strategic anatomical position within the blood vessel wall and acts as a barrier between the blood and vascular smooth muscle. Therefore, the functional integrity of the endothelium is essential to prevent vascular leakage and the formation of vascular diseases [1] . Generation of reactive oxygen species (ROS) by vascular endothelial cells is involved in several clinical conditions such as atherosclerosis, hypercholesteremia and disseminated intravascular coagulation, among others [2, 3] . The up-regulation of ROS in vascular lesions will exert detrimental effects on the peroxidation of membrane lipids, endothelium-derived enzyme inactivation, apoptotic occurrences, etc [4] . In contrast, antioxidants that react preferentially with ROS to inactivate them might have therapeutic applications in treating ROS-induced endothelial injury.
Prostaglandin E 1 (Alprostadil, PGE 1 ), which is an important member of the prostaglandin family, is a product of arachidonic acid metabolism by cyclooxygenase. PGE 1 has vasodilator effects on the systemic and pulmonary circulation [5] and cardio-protective effects during ischemia and reoxygenation [6] . In addition, beneficial effects on angiogenesis, platelet aggregation, blood viscosity and fibrinolysis have been observed [7] [8] [9] [10] [11] [12] [13] . These observations may be partly mediated by nitric oxide (NO) and vascular endothelial growth factor (VEGF) [14] [15] [16] . Moreover, increasing attention has now been paid to the cytoprotective action and anti-oxidant activity of PGE 1 . PGE 1 can protect human retinal pigment epithelial cells against oxidative injury [17] and prevent the production of ROS in the intestinal mucosa of methotrexate-treated rats [18] . However, no direct evidence has been provided about the protective effects of PGE 1 on oxidative stress-induced vascular endothelium dysfunction, which is an important contributor to the development of cardiovascular diseases.
In the present study, we used human umbilical vein endothelial cells (HUVECs) to examine the protective effects of PGE 1 under oxidative stress, as well as the underlying mechanisms involved in this protection. Hoechst 33258 , and N G -Nitro-L-arginine methylester (L-NAME) were obtained from Sigma (St Louis, MO, USA). The reagent kits for the measurement of the levels of LDH, MDA, SOD, NO, and GSH-Px were purchased from Nanjing Institute of Jiancheng Bioengineering (Nanjing, China). The annexin V-FITC apoptosis detection kit was obtained from Jingmei (Shenzhen, China). Rabbit anti-eNOS antibody, mouse anti-β-actin antibody, goat-antirabbit-IgG-HRP, goat-anti-mouse-IgG-HRP and Western blotting Luminol reagent were obtained from Santa Cruz (Santa Cruz, CA, USA). 2′,7′-dichlorofluorescein diacetate (DCFH-DA), TRIzol reagent and M-MLV reverse transcriptase were obtained from Invitrogen (Carlsbad, CA, USA), and Green Real-time PCR Master Mix was from Toyobo (Osaka, Japan). All other reagents used were of analytical grade.
Cell culture and treatment HUVECs were maintained in Endothelial Cell Medium (ECM) supplemented with 5% fetal bovine serum and 1% Endothelial Cell Growth Supplement (ECGS) in Poly-L-Lysine (PLL) pretreated flasks at 37 °C in a 5% CO 2 incubator. HUVECs, ECM, fetal bovine serum, ECGS and PLL were all purchased from Sciencell Research Laboratories (Carlsbad, CA, USA).
HUVECs were pretreated with ECM containing PGE 1 (0.25, 0.50, and 1.00 µmol/L) or Vc (1.5 mmol/L). Then, the culture supernatant was removed and the cells were exposed to H 2 O 2 (200 µmol/L) diluted in ECM for 12 h at 37 °C until further assay.
Cell viability measurement
The viability of HUVECs was measured by the MTT assay [19] . The absorbance (A) at 570 nm in each well was determined with a microplate autoreader (Bio-Rad, Hercules, CA, USA). The viability of HUVECs in each well was presented as a percentage of the control group.
Measurement of intracellular ROS
Measurement of intracellular ROS was based on ROSmediated conversion of nonfluorescent 2′,7′-DCFH-DA into DCFH [20] . Following the same procedure as the incubation studies, cells were harvested and incubated with DCFH-DA (10 µmol/L) diluted in ECM at 37 °C for 30 min. Subsequently, cells were washed with PBS three times and analyzed by flow cytometry performed on a FACScalibur cell analyzer using Cell Quest software (Becton Dickinson, Mountain View, CA, USA).
Preparation of cell lysate
The cells were treated as described above, and the culture supernatant was collected for analysis of LDH and NO release.
The cells were scraped from the plates into ice-cold RIPA lysis buffer and the protein concentration was determined by the bicinchoninic acid (BCA) method, using BSA as a reference standard. Cell lysate was stored at -80 °C until used for the detection of MDA, SOD, and GSH-Px.
Measurement of LDH and NO release, as well as intracellular SOD, GSH-Px and MDA LDH, an indicator of cell injury, was detected after exposure to H 2 O 2 with an assay kit according to the manufacturer's protocol. Enzyme activity was expressed as units per liter and the absorbance was read at 440 nm.
The concentration of nitrites (NO 2 − ) and nitrates (NO 3 − ), stable end products of nitric oxide (NO), was determined by the Griess reaction. NO production was determined by measuring the optical density at 550 nm and was expressed in units per liter.
The concentration of MDA and the activities of SOD and GSH-Px were determined using commercially available kits. All procedures complied with the manufacturer's instructions. The results of the MDA, SOD, and GSH-Px assays were expressed as units per milligram of protein. The assay for SOD activity was based on its ability to inhibit the oxidation of hydroxylamine by O 2 · produced from the xanthine-xanthineoxiase system. One unit of SOD activity was defined as the amount that reduced the absorbance at 550 nm by 50%. The assay for GSH-Px activity was assayed by quantifying the rate of oxidation of reduced glutathione to oxidized glutathione by H 2 O 2 , as catalyzed by GSH-Px. One unit of GSH-Px was defined as the amount that reduced the level of GSH at 412 nm by 1 μmol/L in 1 min/mg protein. MDA was measured at a wavelength of 532 nm by reacting with thiobarbituric acid (TBA) to form a stable chromophoric product. Values for the MDA level were expressed in units per milligram of protein.
Flow cytometric evaluation of apoptosis Cells grown in 6-well plates were harvested and washed. Samples were double-stained by Annexin V-FITC and propidium iodide (PI) at room temperature for 30 min in the dark and quantitatively analyzed by flow cytometry performed on a FACScalibur cell analyzer using CellQuest software (Becton Dickinson, Mountain View, CA, USA).
Nuclear morphology
Cell death was determined by Hoechst 33258 and PI double fluorescent staining. Cells were cultured on cover slides and treated as described previously. Samples were stained with PI (10 μg/mL) and Hoechst 33258 (10 μg/mL) and then fixed with 4% paraformaldehyde. For each cover slide, 1000−1500 cells were examined under a fluorescence microscope (Olympus Corp, Tokyo, Japan) and photographed with a digital camera (Olympus DP70, Japan).
Western blot analysis
Samples (40 μg protein) from the cell lysate were applied to 10% SDS-PAGE, followed by transfer to nitrocellulose mem-www.chinaphar.com Fang WT et al Acta Pharmacologica Sinica npg branes. Blots were then blocked with 5% skim milk in TBST for 1 h and incubated with rabbit anti-eNOS and mouse anti-β-actin antibodies at dilutions recommended by the supplier. Then, the membrane was washed, and primary antibodies were detected with goat-anti-rabbit-IgG-HRP or goat-antimouse-IgG-HRP. Protein expression levels were determined by analyzing the signals captured on the nitrocellulose membranes using Western blotting Luminol reagent and Konica X-ray film (Konica, Tokyo, Japan).
Quantitative real-time PCR assays Total RNA was isolated using TRIzol reagent according to the manufacturer's instructions. The cDNA was synthesized from 2 µg RNA using M-MLV reverse transcriptase. Real-time quantitative PCR analysis was carried out in a MyiQ single color real time PCR detection instrument (Bio-Rad, Hercules, CA, USA). Specific sense and antisense primers used were as follows: eNOS sense: 5′-CCTTCTGTGTGGGAGAGGAT-3′, and antisense: 5′-TTGTAGCCTGGAACATCTTCC-3′; β-actin sense: 5′-CACTGTGTTGGCGTACAGGT-3′, and anti-sense 5′-TCATCACCATTGGCAATGAG-3′. The reaction was conducted with an initial denaturing step at 95 °C for 30 s, followed by 40 cycles of 95 °C for 5 s, 55 °C for 10 s and 72 °C for 15 s. The reaction was terminated by a cooling step at 4 °C. Each experiment was performed in duplicate and all data were analyzed using Bio-Rad iQ5 Software.
Statistical analysis
All values are expressed as the mean±SD. The data were analyzed by a one-way ANOVA and a two-tailed Student's t-test. P<0.05 was considered statistically significant. Figure 1A) . However, pretreatment with PGE 1 (0.25, 0.50, and 1.00 µmol/L) dose-dependently increased the viability of H 2 O 2 -induced HUVECs. This effect of PGE 1 was significantly attenuated by the NO-inhibitor L-NAME. When incubated with 0.0625−2.00 µmol/L PGE 1 alone for 24 h, cell viability did not show marked changes compared with the control group, but significant cytotoxicity was observed with the 4.00 µmol/L PGE 1 treatment for 24 h (data not shown). Therefore, a range of 0.25−1.00 µmol/L PGE 1 concentrations was used throughout subsequent experiments. Furthermore, addition of PGE 1 (0.25, 0.50, and 1.00 µmol/L) simultaneously with or immediately after H 2 O 2 treatment also produced protective outcomes (Figure 2) .
Results

Effects
To further investigate the protective effects of PGE 1 , the LDH assay, another indicator of cell toxicity, was performed. Intracellular radical scavenging ability of PGE 1 The intracellular ROS concentration was determined by measuring the intensity of DCFH fluorescence, as the intensity of fluorescence reflects enhanced oxidative stress.
The DCFH fluorescence intensity in the H 2 O 2 -treated control group increased to 244.82%±7.24%, whereas pre-incubation with PGE 1 (0.25, 0.50, and 1.00 µmol/L) significantly reduced the increase in fluorescence induced by H 2 O 2 in a concentration-dependent manner (Figure 3 ).
Effects of PGE 1 on SOD and GSH-Px activities and MDA content The effects of PGE 1 on lipid peroxidation and endogenous antioxidant preservation were also measured. Treatment with H 2 O 2 (200 µmol/L, 12 h) decreased the activities of SOD and GSH-Px to 59.6%±6.42% and 54.3%±4.49%, respectively, compared to no treatment. However, pre-incubation with PGE 1 (0.25, 0.50, and 1.00 µmol/L) or Vc (1.5 mmol/L) significantly attenuated the changes in SOD and GSH-Px activity (Table 1) Figure 4C, 4D, 4E ). In the control group, little morphological sign of nuclear damage or chromatin condensation was observed ( Figure 5A Figure  5B ). However, pre-incubation with PGE 1 (0.25, 0.50, and 1.00 µmol/L) before H 2 O 2 -injury significantly attenuated cell damage ( Figure 5C , 5D, 5E). Detection of NO release in culture supernatant and expression of eNOS protein and mRNA in HUVECs To investigate the mechanisms that mediate the antioxidative effect of PGE 1 , the NO release and eNOS expression were measured. Pre-incubation with PGE 1 (0.25, 0.50, and 1.00 µmol/L) was observed to significantly increase NO content in a dosedependent manner ( Figure 6A ). However, co-incubation with 1 μmol/L L-NAME and PGE 1 for 24 h before H 2 O 2 treatment significantly reduced NO release, as well as cell viability, compared to the PGE 1 treatment group ( Figures 1A and 6A ). In parallel, the eNOS protein ( Figure 6B ) and mRNA ( Figure  6D ) levels in HUVECs were also assayed. Pre-incubation with PGE 1 (0.25, 0.50, and 1.00 µmol/L) also triggered eNOS protein and mRNA expression markedly in a dose-dependent manner. These results were consistent with the observed change in NO content over the course of the experiments.
Discussion
The results presented here indicated that PGE 1 protected endothelial cells from H 2 O 2 -induced injury. It decreased the amount of ROS, LDH, and MDA, decreased the percentage of apoptotic cells and increased SOD and GSH-Px activity. Furthermore, PGE 1 increased NO release and upregulated eNOS protein and mRNA expression.
Oxidative stress plays a critical role in endothelial dysfunction [21] and is a critical pathogenic factor in the development of cardiovascular diseases, such as atherosclerosis, hypercholesteremia and disseminated intravascular coagulation [22] . Here, we demonstrated that H 2 O 2 , a precursor of other ROS, can markedly increase cell permeability, damage cellular antioxidant defenses and induce endothelial cell apoptosis at 200 µmol/L.
Agents that inhibit production of ROS or enhance cellular antioxidant defenses can protect cells from the damaging effects of oxygen radicals [23] . Our study first proved that PGE 1 not only strikingly scavenged intracellular ROS induced by H 2 O 2 ( Figure 3 ), but also effectively increased the viability of H 2 O 2 -induced endothelial cells (Figure 1 ). Miho et al suggest that PGE 1 protects human retinal pigment epithelial cells from oxidative injury [17] and prevents the production of ROS in the intestinal mucosa of methotrexate-treated rats [18] . These results indicate that the protective effect is associated with PGE 1 scavenging intracellular ROS.
Lipid peroxidation is one of the primary events in free radical-mediated cell injury. MDA is a by-product of lipid peroxidation induced by excessive ROS and is widely used as a biomarker of oxidative stress [24] . Antioxidant enzymes, such as SOD and GSH-Px, however, are thought to be effective for the augmentation of antioxidant defenses in endothelial cells [25] . In our study, when endothelial cells were incubated with PGE 1 , these H 2 O 2 -induced cellular events were almost completely blocked (Table 1) . These results jointly suggest that the scavenging of ROS might be related to the increased activities of antioxidant enzymes.
Hydrogen peroxide not only decreased the viability of cells, but also induced cell apoptosis [21] . Previous studies have shown that PGE 1 protects human liver sinusoidal endothelial cells and endothelial progenitor cells from apoptosis [26, 27] . In the present study, we demonstrate that 200 μmol/L H 2 O 2 induces massive cell apoptosis, while PGE 1 (0.25−1.00 µmol/L) prevents the H 2 O 2 -induced apoptosis in a concentrationdependent manner (Figures 4 and 5) . Thus, we presumed that PGE 1 prevented cell apoptosis due to decreased intracellular ROS and increased antioxidant enzymatic activities.
Nitric oxide (NO) is a soluble gas continuously synthesized by the endothelium and has a wide range of biological properties that maintain vascular homeostasis, including modulation of vascular dilator tone, regulation of local cell growth, and [28] . Endothelial dysfunction, defined as impaired endothelium-dependent vasorelaxation, is usually attributed to a deficiency of nitric oxide [29] . Our studies show that pretreatment with PGE 1 significantly increases NO and eNOS expression compared to H 2 O 2 -alone ( Figure  6 ). The increasing NO content is paralleled by a reduction of cell injury induced by H 2 O 2 ( Figures 1A and 6A) . NO terminates chain reactions during lipid peroxidation, as observed in model lipid systems of low-density lipoprotein oxidation and in cells [14, 30] . These results suggest that the NO pathway plays an important role in the protective activity of prostaglandin E 1 against H 2 O 2 -induced oxidative injury, but the mechanisms are still unclear. PGE 1 activates adenylate cyclase and increases intracellular cAMP via binding to prostanoid receptor subtypes EP2, EP3, EP4, and IP [31] . The cAMP-responsive elements (CRE) within the human eNOS promoter play an important role in the inducible expression of the human eNOS gene [32, 33] . Progressive 5′-deletion and site-specific mutation analyses defined the beraprost-responsive sequences as CRE, located at -733 and -603 within the human eNOS promoter [32, 33] , and the hypoxia- [34] , while the PGE 1 -responsive sequences are still unclear. PGE 1 increases eNOS expression through PKA pathway activation and cAMPresponsive element binding protein (CREB) phosphorylation. Phosphorylated CREB predominantly binds to CRE, which leads to increased promoter activity and upregulation of the eNOS protein and mRNA expression [32] [33] [34] . Previous studies have also reported that PKA signaling increased phosphorylation of Ser-1177 and dephosphorylation of Thr-495 to activate eNOS, which led to the upregulation of NO [35] . Activation of perinuclear EP3 receptors induced eNOS expression, which depends on nuclear envelope K (Ca) channels, protein kinases, and NF-kappaB [36] . Studies also showed that MAPK is a central pathway to transmit the actions of PGE 1 on eNOS [14] . The mechanism by which PGE 1 upregulates NO expression requires further research before it is well understood.
As our study was limited to the cell level, further studies are needed to confirm the cardiovascular protective effect of PGE 1 in organs or humans. As stated above, we concluded that pretreatment of HUVECs with PGE 1 significantly protected those cells from H 2 O 2 -induced cell death, which was mediated, at least in part, by a mechanism linked to the up-regulation of NO expression. It is noteworthy that the finding of the present study may shed light on the pharmacological basis for the clinical application of PGE 1 for the treatment of atherosclerosis and acute coronary syndrome, which are relevant to endothelial cell death.
